Certara (HAM:700) Short-Term Debt : €2.8 Mil (As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Certara Short-Term Debt?

Certara's Short-Term Debt for the quarter that ended in Jun. 2024 was €2.8 Mil.

Certara's quarterly Short-Term Debt increased from Dec. 2023 (€2.8 Mil) to Mar. 2024 (€2.8 Mil) and increased from Mar. 2024 (€2.8 Mil) to Jun. 2024 (€2.8 Mil).

Certara's annual Short-Term Debt increased from Dec. 2021 (€2.7 Mil) to Dec. 2022 (€2.9 Mil) but then declined from Dec. 2022 (€2.9 Mil) to Dec. 2023 (€2.8 Mil).

Certara Short-Term Debt Historical Data

The historical data trend for Certara's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Certara Short-Term Debt Chart

Certara Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

3.79

3.85

2.67

2.85

2.77

Certara Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Short-Term Debt	Get a 7-Day Free Trial															2.79	2.83	2.77	2.78	2.79

Certara Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Certara Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Certara's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Certara Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Certara Inc (HAM:700) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

CERT:USA

Address

100 Overlook Center, Suite 101, Princeton, NJ, USA, 08540

Website

https://www.certara.com

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The group has a business presence in the United States, EMEA, and other regions, of which a majority of revenue is derived from the United States.

Certara Headlines

No Headlines